MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Clinical characteristics associated with early discontinuation of Levodopa-Carbidopa Intestinal Gel infusion in patients with advanced Parkinson Disease.

    D. Rivero-Rodríguez, M. Morales-Casado, G. Tabar-Comellas, A. Diezma-Martín, P. Quintana-Castro, M. Ennazeh, N. López-Ariztegui (Toledo, Spain)

    Objective: To determine the clinical characteristics associated with early withdrawal of Levodopa-Carbidopa Intestinal Gel infusion (LCIG) in patients with advanced Parkinson´s Disease (APD) Background: LCIG…
  • 2024 International Congress

    Writing rehabilitation in parkinson’s disease (pd) through a virtual workshop

    F. Echeverria, P. Sanchez Diaz, S. Revellini, G. Costa, G. Ziegler, S. Rodriguez Quiroga, T. Arakaki, N. Garretto (Buenos Aires, Argentina)

    Objective: Evaluate the effect of intensive writing training through a virtual workshop once a week and the potential influence in the quality of life in…
  • 2024 International Congress

    Parkin regulates ER-mitochondria association through interaction with IP3R-Grp75-VDAC1

    NJ. Xue, Y. Liu, ZH. Lin, BR. Zhang, JL. Pu (Hangzhou, China)

    Objective: The objective of this study is to explore how Parkin modulates the interplay between mitochondria and the endoplasmic reticulum (ER), along with elucidating its…
  • 2024 International Congress

    Gut Microbial Metabolites and Future Risk of Parkinson’s Disease: A Metabolome-wide Association Study

    Y. Zhao, Y. Lai, S. Darweesh, B. Bloem, L. Forsgren, J. Hansen, JM. Huerta, M. Guevara, C. Lill, G. Miller, S. Peters, R. Vermeulen (Utrecht, Netherlands)

    Objective: To prospectively investigate the association between plasma microbial metabolites and Parkinson’s disease (PD) risk within a metabolomics framework. Background: Gut microbiota is altered in…
  • 2024 International Congress

    A Machine Learning Approach for Early Identification of Prodromal Parkinson’s Disease

    A. Vaish (Redmond, USA)

    Objective: The aim of this project is to analyze available data of voice, Tappy keystroke, spiral drawings, and gait sample data involving PD patients and…
  • 2024 International Congress

    First in vivo evidence of the role of the noradrenergic system in olfactory dysfunction in Parkinson’s disease

    C. Laurencin, S. Lancelot, S. Brosse, J. Redouté, I. Mérida, D. Le Bars, N. Costes, S. Thobois, P. Boulinguez, B. Ballanger (lyon, France)

    Objective: To investigate the relationship between in vivo noradrenergic markers and olfactory impairment in patients with Parkinson’s disease (PD). Background: Degeneration of the noradrenergic (NA)…
  • 2024 International Congress

    Dopamine Transporter Imaging as Monitoring Biomarker in Parkinson’s Disease

    V. Dzialas, G. Bischof, K. Möllenhoff, A. Drzezga, T. van Eimeren (Cologne, Germany)

    Objective: To investigate the longitudinal relationship between changes in dopamine transporter single-photon emission computed tomography (DaT SPECT) and changes in motor symptom severity in Parkinson’s…
  • 2024 International Congress

    Data-driven image-based subtyping and staging of neurodegeneration in Parkinson’s disease

    J. Ha, G. Park, JS. Lee, JH. Ahn, W. Kim, JW. Cho, H. Kim, J. Youn (Seoul, Republic of Korea)

    Objective: We aimed to conduct image-based, data-driven classification of Parkinson’s disease (PD) progression using event-based modeling (EBM) and derive neuropathological insights from the results. Background:…
  • 2024 International Congress

    Characterizing levodopa-induced dyskinesias using multimodal neuroimaging, clinical and behavioral measures

    S. Shukla, S. Tinaz, N. Thirugnanasambandam (Mumbai, India)

    Objective: Our objective is to investigate potential differential modulation in motor and executive function networks among patients with LID, and to explore its correlation with…
  • 2024 International Congress

    Clinical Trends and Clinician Perceptions Regarding Asleep and Awake DBS

    Y. Gordeyeva, B. Dalm, L. Almeida, S. de Jesus, A. Fasano, K. Foote, J. Jimenez-Shahed, D. Pathadan, N. Pouratian, J. Rolston, J. Rosenow, D. Safarpour, J. Schwalb, M. Siddiqui, M. Spindler, A. Tsai, J. Wong, L. Metman (Poznan, Poland)

    Objective: To determine trends and perceptions regarding Asleep and Awake Deep Brain Stimulation (DBS) in the USA and abroad. Background: DBS clinical practice continues to…
  • « Previous Page
  • 1
  • …
  • 305
  • 306
  • 307
  • 308
  • 309
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley